What is Artel?
Headquartered in Westbrook, Maine, Artel serves as a critical infrastructure provider for laboratories worldwide. The company specializes in quality assurance systems designed to validate the performance of automated liquid handling instrumentation and manual pipettes. By offering a comprehensive suite of support, training, and consultation services, Artel ensures that high-throughput research and clinical environments maintain rigorous standards of accuracy and reproducibility. Their market position is defined by a commitment to technical precision, enabling laboratories to mitigate risks associated with fluid measurement errors in sensitive scientific workflows.
How much funding has Artel raised?
Artel has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Artel
PPP
Public-Private Partnership
What's next for Artel?
With the infusion of this major enterprise-level funding, Artel is expected to accelerate its strategic initiatives aimed at scaling its service delivery model and enhancing its technological portfolio. The capital will likely be deployed to deepen the integration of its quality assurance platforms within global laboratory networks, potentially focusing on the automation of compliance reporting and the expansion of its consultative reach. As the demand for reliable, high-precision laboratory data continues to rise, Artel's focus on customizable support and instrumentation validation will remain a cornerstone of its growth strategy, ensuring it remains a vital partner for organizations navigating complex regulatory landscapes.
See full Artel company page
